158 related articles for article (PubMed ID: 20012656)
1. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Janik P; Kwiecinski H; Sokolowska B; Niebroj-Dobosz I
J Neural Transm (Vienna); 2010 Mar; 117(3):343-7. PubMed ID: 20012656
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and amyotrophic lateral sclerosis: Plasma level determination.
Carilho R; de Carvalho M; Kuehl U; Pinto S; Pinto A; Kromminga A; Costa J
Amyotroph Lateral Scler; 2011 Nov; 12(6):439-43. PubMed ID: 21722017
[TBL] [Abstract][Full Text] [Related]
4. High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia.
Just N; Moreau C; Lassalle P; Gosset P; Perez T; Brunaud-Danel V; Wallaert B; Destée A; Defebvre L; Tonnel AB; Devos D
Neuromuscul Disord; 2007 Feb; 17(2):169-73. PubMed ID: 17142042
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Zheng Y; Gao L; Wang D; Zang D
Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
Brettschneider J; Widl K; Ehrenreich H; Riepe M; Tumani H
Neurosci Lett; 2006 Sep; 404(3):347-51. PubMed ID: 16815630
[TBL] [Abstract][Full Text] [Related]
8. Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis.
Iłzecka J; Kocki T; Stelmasiak Z; Turski WA
Acta Neurol Scand; 2003 Jun; 107(6):412-8. PubMed ID: 12757473
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
13. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
[TBL] [Abstract][Full Text] [Related]
15. VEGF levels in CSF and serum in mild ALS patients.
Gao L; Zhou S; Cai H; Gong Z; Zang D
J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
[TBL] [Abstract][Full Text] [Related]
16. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kasai T; Tokuda T; Ishigami N; Sasayama H; Foulds P; Mitchell DJ; Mann DM; Allsop D; Nakagawa M
Acta Neuropathol; 2009 Jan; 117(1):55-62. PubMed ID: 18989684
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.
Xenocostas A; Cheung WK; Farrell F; Zakszewski C; Kelley M; Lutynski A; Crump M; Lipton JH; Kiss TL; Lau CY; Messner HA
Eur J Clin Pharmacol; 2005 May; 61(3):189-95. PubMed ID: 15776276
[TBL] [Abstract][Full Text] [Related]
18. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
Liu J; Gao L; Zang D
PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.
Iłzecka J
Acta Neurol Scand; 2003 Aug; 108(2):125-9. PubMed ID: 12859290
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis.
Iłzecka J; Stelmasiak Z; Dobosz B
Cytokine; 2002 Dec; 20(5):239-43. PubMed ID: 12550109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
